N-terminal pro-B-type natriuretic peptide levels increases after hyperbaric oxygen therapy in diabetic patients

Clinical and Investigative Medicine

Volumn 31, Issue 5, 2008, Pages

  Yildiz, Senol ^a   Uzun, Gunalp ^a   Uz, Omer ^a   Ipcioglu, Osman Metin ^a   Kardesoglu, Ejder ^a   Ozcan, Omer ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HUMAN; HYPERBARIC OXYGEN; MALE; PRIORITY JOURNAL; VENOUS BLOOD;

AGED; BIOLOGICAL MARKERS; DIABETIC FOOT; FEMALE; HEART VENTRICLES; HUMANS; HYPERBARIC OXYGENATION; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES;

EID: 52949133020     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ali Raza J, Movahed A. Current concepts of cardiovascular diseases in diabetic patients. Int J Cariol. 2003;89:123-34.
2. Neubauer B, Tetzlaff K, Staschen CM, Bettinghausen E. Cardiac output changes during hyperbaric hyperoxia. Int Arch Occup Environ Health. 2001;74:119-22.
3. Abel FL, McNamee JE, Cone DL, Clarke D, Tao J. Effects of hyperbaric oxygen on ventricular performance, pulmonary blood volume, and systemic and pulmonary vascular resistance. Undersea Hyperb Med. 2000;27:67-73.
4. Molénat F, Boussuges A, Grandfond A, et al. Haemodynamic effects of hyperbaric hyperoxia in healthy volunteers: an echocardiographic and Doppler study. Clin Sci (Lond). 2004;106:389-95.
5. Weaver LK, Churchill S. Pulmonary edema associated with hyperbaric oxygen therapy. Chest. 2001;120:1407-9.
6. Due-Andersen R, Pedersen-Bjergaard U, Hoi-Hansen T et al. NT-proBNP during hypoglycemia and hypoxemia in normal subjects: Impact of renin angiotensin system (RAS) activity. J Appl Physiol. 2008;104:1080-5.
7. Mantymaa P, Vuolteenaho O, Marttila M, Ruskoaho H. Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro. Endocrinology 1993;133:1470-3.
8. Magga J, Marttila M, Mantymaa P, Vuolteenaho O, Ruskoaho H. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin and phenylephrine-infused conscious rats. Endocrinology 1994;134:2505-15.
9. Iwanaga Y, Nishi I, Furuichi S, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure. Comparison between systolic and diastolic heart failure. J Am Coll Cardiol. 2006;47:742-8.
10. Pemberton CJ, Johnson ML, Yandle TG, Espiner EA. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension. 2000;36:355-9.
11. Grassi P, Buscema G, Rinaldi A, Gobbato PE, Berlot G. B-type natriuretic peptide in healthy subjects after exposure to hyperbaric oxygen at 2.5 ATA. Aviat Space Environ Med. 2007;78:52-3.
12. Sheikh AY, Gibson JJ, Rollins MD, Hopf HW, Hussain Z, Hunt TK. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch Surg. 2000;135:1293-7.
13. Magnusson M, Melander O, Israelsson B, Grubb A, Groop L, Jovinge S. Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care. 2004;27:1929-35.
14. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications Endocrine Reviews. 2004;25:543-567.